Patients with COVID-19 | All | Clinical consensus | P value | |
No storm | Storm | |||
Numbers | 513 | 449 | 64 | <0.001 |
% | 100 | 88 | 12 | |
Sex (%) | ||||
Females | 43 | 45 | 33 | <0.001 |
Males | 57 | 55 | 66 | |
Age (years) | 58.3 | 57.7 | 62.2 | 0.041 |
Race/ethnicity (%) | ||||
AA | 53 | 54 | 53 | n.s. |
EA | 11 | 11 | 14 | n.s. |
Hispanic | 23 | 22 | 19 | n.s. |
Other | 9 | 9 | 9 | n.s. |
Unknown | 4 | 4 | 5 | n.s. |
Comorbidities (%) | ||||
Lung disease | 26 | 24 | 36 | 0.077 |
Hypertension | 69 | 68 | 72 | n.s. |
Obesity | 52 | 51 | 55 | n.s. |
Heart disease | 25 | 25 | 25 | n.s. |
Smoking history | 42 | 43 | 36 | n.s. |
Diabetes | 48 | 50 | 36 | 0.057 |
Patients with diagnosis of COVID-19 infection and chest high-resolution CT with ground-glass opacity were divided according to a consensus of clinicians for a diagnosis of cytokine storm. P values were calculated using χ2 test for frequencies and t-test for age.
Italics indicate significant p values.
AA, African–American; EA, European–American; n.s., not significant at α≥0.05.